Charalabos-Markos Dintsios

Dr. Charalabos-Markos Dintsios

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2011 in International Journal of Technology Assessment in Health Care
Verified
Journal Article
Closed access
PDF file
MDMarion Danner
Marion Danner
JHJ. Marjan Hummel
J. Marjan Hummel
FVFabian Volz
Fabian Volz
JMJeannette G. van Manen
Jeannette G. van Manen
BWBeate Wiegard
Beate Wiegard
MIMaarten J. IJzerman
Maarten J. IJzerman
Background: Patient involvement is widely acknowledged to be a valuable component in health technology assessment (HTA) and healthcare decision making. However, quantitative approaches to ascertain patients' preferences for treatment endpoints are not yet established. The objective of this study is to introduce the analytic hierarchy process (AHP) as a preference elicitation method in HTA. Based on a systematic literature review on the use of AHP in health care in 2009, the German Institute for Quality and Efficiency in Health Care (IQWiG) initiated an AHP study related to its HTA work in 2010.Methods: The AHP study included two AHP workshops, one with twelve patients and one with seven healthcare professionals. In these workshops, both patients and professionals rated their preferences with respect to the importance of different endpoints of antidepressant treatment by a pairwise comparison of individual endpoints. These comparisons were performed and evaluated by the AHP method and relative weights were generated for each endpoint.Results: The AHP study indicates that AHP is a well-structured technique whose cognitive demands were well handled by patients and professionals. The two groups rated some of the included endpoints of antidepressant treatment differently. For both groups, however, the same six of the eleven endpoints analyzed accounted for more than 80 percent of the total weight.Conclusions: AHP can be used in HTA to give a quantitative dimension to patients' preferences for treatment endpoints. Preference elicitation could provide important information at various stages of HTA and challenge opinions on the importance of endpoints.

16 June 2013 in The European Journal of Health Economics
Verified
Journal Article
Open access
PDF file
JRJörg Ruof
Jörg Ruof
FSFriedrich Wilhelm Schwartz
Friedrich Wilhelm Schwartz
JSJ.-Matthias Schulenburg
J.-Matthias Schulenburg
CDCharalabos-Markos Dintsios
Charalabos-Markos Dintsios
Since the introduction of the German health care reform in January 2011, an early benefit assessment (EBA) is required for all new medicines. Pharmaceutical manufacturers have to submit a benefit dossier for evaluation by the Institute for Quality and Efficiency in Health Care (IQWiG). A final decision is made by the Federal Joint Committee (G-BA). The aim of this investigation was to analyse the outcomes 18 months after introduction of the new legislation and to identify critical areas requiring further discussion and development.

4 February 2016 in The European Journal of Health Economics
Verified
Journal Article
Closed access
PDF file
Axel C. MühlbacherAxel C. Mühlbacher
Axel C. Mühlbacher
JBJohn F. P. Bridges
John F. P. Bridges
SBSusanne Bethge
Susanne Bethge
CDCharalabos-Markos Dintsios
Charalabos-Markos Dintsios
ASAnja Schwalm
Anja Schwalm
MNMatthias Nübling
Matthias Nübling

23 December 2012 in The Patient - Patient-Centered Outcomes Research
Verified
Journal Article
Closed access
PDF file
MHMarjan J. M. Hummel
Marjan J. M. Hummel
FVFabian Volz
Fabian Volz
JMJeannette G. van Manen
Jeannette G. van Manen
MDMarion Danner
Marion Danner
CDCharalabos-Markos Dintsios
Charalabos-Markos Dintsios
AGAndreas Gerber
Andreas Gerber

6 October 2010 in International Journal of Technology Assessment in Health Care
Verified
Journal Article
Closed access
PDF file
SDSigrid Droste
Sigrid Droste
CDCharalabos-Markos Dintsios
Charalabos-Markos Dintsios
AGAndreas Gerber
Andreas Gerber
Background: Comprehensive health technology assessments (HTAs) include thorough reflections on ethical issues associated with health technologies, their use, and value-based decisions in the assessment process. As methods of information retrieval for effectiveness assessments are not applicable to information retrieval on ethical issues, a specific methodological approach is necessary.Objectives: In the absence of existing adapted methods, our objective was to develop a methodological approach for the systematic retrieval of information on ethical issues related to health technologies.Method and Results: A literature search was conducted to verify the non-existence of published comprehensive methodological approaches for the information retrieval on ethical issues for HTAs, and resulted in no hits. We, therefore, developed a step-by-step workflow following the workflow of information retrieval for effectiveness assessments: Step 1: Translation of the search question using the PICO scheme and additional components. Step 2: Concept building by modeling and linking search components. Step 3: Identification of synonyms in all relevant languages. Step 4: Selection of relevant information sources. Step 5: Design of search strategies for bibliographic databases. Step 6: Execution of search strategies and information seeking, including hand-searching. Step 7: Saving of retrieval results and standardized reporting of the process and results. Step 8: Final quality check and calculation of precision and recall.Conclusions: Systematic searching for information on ethical issues related to health technologies can be performed following the common retrieval workflow for effectiveness assessments, but should be performed separately applying adapted procedures and search terms on ethical issues relevant to the research question.

1 July 2011 in PharmacoEconomics
Verified
Journal Article
Closed access
PDF file
AGAndreas Gerber
Andreas Gerber
SSStephanie Stock
Stephanie Stock
CDCharalabos-Markos Dintsios
Charalabos-Markos Dintsios